Rtw Investments as of Sept. 30, 2020
Portfolio Holdings for Rtw Investments
Rtw Investments holds 90 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 9.3 | $384M | 17M | 22.86 | |
| Immunovant (IMVT) | 6.4 | $264M | 7.5M | 35.19 | |
| Alnylam Pharmaceuticals (ALNY) | 5.9 | $245M | 1.7M | 145.60 | |
| Ptc Therapeutics I (PTCT) | 4.5 | $187M | 4.0M | 46.75 | |
| Mirati Therapeutics | 4.4 | $182M | 1.1M | 166.05 | |
| Dicerna Pharmaceuticals | 3.1 | $130M | 7.2M | 17.99 | |
| Myokardia | 3.1 | $128M | 937k | 136.33 | |
| Natera (NTRA) | 3.0 | $124M | 1.7M | 72.24 | |
| Axsome Therapeutics (AXSM) | 2.9 | $119M | 1.7M | 71.25 | |
| Stoke Therapeutics (STOK) | 2.9 | $119M | 3.5M | 33.49 | |
| Avidity Biosciences Ord (RNA) | 2.6 | $110M | 4.0M | 27.51 | |
| Masimo Corporation (MASI) | 2.6 | $106M | 450k | 236.06 | |
| Cerner Corporation | 2.4 | $101M | 1.4M | 72.29 | |
| Axonics Modulation Technolog (AXNX) | 2.3 | $96M | 1.9M | 51.04 | |
| Baxter International (BAX) | 2.1 | $87M | 1.1M | 80.42 | |
| 10x Genomics Cl A Com (TXG) | 2.0 | $82M | 661k | 124.68 | |
| Adverum Biotechnologies | 1.8 | $75M | 7.2M | 10.30 | |
| Vericel (VCEL) | 1.7 | $71M | 3.9M | 18.53 | |
| Tandem Diabetes Care Com New (TNDM) | 1.6 | $69M | 604k | 113.50 | |
| Protagonist Therapeutics (PTGX) | 1.6 | $67M | 3.4M | 19.55 | |
| Relmada Therapeutics (RLMD) | 1.4 | $57M | 1.5M | 37.62 | |
| Illumina (ILMN) | 1.3 | $54M | 175k | 309.08 | |
| Guardant Health (GH) | 1.3 | $53M | 470k | 111.78 | |
| Agenus Com New | 1.2 | $52M | 13M | 4.00 | |
| Translate Bio | 1.2 | $51M | 3.7M | 13.61 | |
| Frequency Therapeutics | 1.1 | $47M | 2.5M | 19.21 | |
| Celldex Therapeutics Com New (CLDX) | 1.1 | $46M | 3.1M | 14.83 | |
| Athira Pharma (ATHA) | 1.1 | $45M | 2.7M | 17.00 | |
| Establishment Labs Holdings Ord (ESTA) | 1.0 | $43M | 2.3M | 18.53 | |
| Nanostring Technologies (NSTGQ) | 1.0 | $42M | 947k | 44.70 | |
| Cytokinetics Inc Private Com New (CYTK) | 1.0 | $41M | 2.0M | 20.35 | |
| Oyster Point Pharma | 1.0 | $41M | 1.9M | 21.11 | |
| Castle Biosciences (CSTL) | 0.9 | $38M | 744k | 51.45 | |
| Iveric Bio | 0.9 | $38M | 6.7M | 5.64 | |
| Dermtech Ord ord (DMTKQ) | 0.8 | $35M | 2.9M | 11.95 | |
| Macrogenics (MGNX) | 0.8 | $32M | 1.3M | 25.19 | |
| Milestone Pharmaceuticals (MIST) | 0.8 | $32M | 4.3M | 7.32 | |
| Trillium Therapeutics Com New | 0.7 | $31M | 2.2M | 14.21 | |
| Incyte Corporation (INCY) | 0.7 | $30M | 334k | 89.74 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.7 | $27M | 5.4M | 5.04 | |
| Homology Medicines | 0.6 | $27M | 2.5M | 10.70 | |
| OraSure Technologies (OSUR) | 0.6 | $25M | 2.1M | 12.17 | |
| ProQR Therapeutics NV Shs Euro (PRQR) | 0.6 | $24M | 5.0M | 4.79 | |
| Vaxart Com New (VXRT) | 0.6 | $23M | 3.5M | 6.65 | |
| Berkeley Lts | 0.6 | $23M | 300k | 76.36 | |
| Tela Bio (TELA) | 0.5 | $23M | 1.4M | 16.54 | |
| Johnson & Johnson (JNJ) | 0.5 | $22M | 150k | 148.88 | |
| Iteos Therapeutics (ITOS) | 0.5 | $21M | 903k | 23.15 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.5 | $21M | 2.6M | 7.98 | |
| Outset Med (OM) | 0.5 | $20M | 405k | 50.00 | |
| Arbutus Biopharma (ABUS) | 0.5 | $19M | 6.0M | 3.13 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $18M | 500k | 35.50 | |
| Altimmune Com New (ALT) | 0.4 | $18M | 1.3M | 13.20 | |
| MiMedx (MDXG) | 0.4 | $17M | 2.7M | 6.36 | |
| Immunic (IMUX) | 0.4 | $17M | 913k | 18.57 | |
| Apyx Medical Corporation (APYX) | 0.4 | $16M | 3.4M | 4.71 | |
| Amyris Com New | 0.4 | $15M | 5.2M | 2.92 | |
| Exagen (XGN) | 0.3 | $14M | 1.3M | 10.84 | |
| Acutus Medical (AFIB) | 0.3 | $14M | 452k | 29.80 | |
| Odonate Therapeutics Ord | 0.3 | $13M | 999k | 13.43 | |
| GenMark Diagnostics | 0.3 | $11M | 763k | 14.20 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.3 | $11M | 251k | 42.90 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $10M | 1.5M | 6.65 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 0.2 | $9.7M | 2.4M | 4.03 | |
| Bellus Health Com New | 0.2 | $9.5M | 4.2M | 2.28 | |
| Itamar Medical Sponsored Ads | 0.2 | $9.3M | 457k | 20.43 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $9.1M | 1.2M | 7.93 | |
| Inmode SHS (INMD) | 0.2 | $9.0M | 250k | 36.18 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $8.8M | 318k | 27.52 | |
| argenx SE Sponsored Adr (ARGX) | 0.2 | $8.3M | 32k | 262.53 | |
| Therapeutics Acquisition Corp Com Cl A | 0.2 | $7.0M | 490k | 14.38 | |
| Transmedics Group (TMDX) | 0.2 | $6.9M | 503k | 13.78 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.2 | $6.8M | 500k | 13.60 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $6.5M | 1.1M | 5.83 | |
| Bctg Acquisition Corp | 0.1 | $6.2M | 600k | 10.36 | |
| Clearside Biomedical (CLSD) | 0.1 | $6.1M | 3.9M | 1.54 | |
| Uniqure NV SHS (QURE) | 0.1 | $5.8M | 159k | 36.83 | |
| Equillium (EQ) | 0.1 | $5.8M | 1.0M | 5.77 | |
| Personalis Ord (PSNL) | 0.1 | $5.5M | 255k | 21.67 | |
| Arya Sciences Acquisition II Corp Unit 06/09/2027 | 0.1 | $5.5M | 500k | 11.00 | |
| Arya Sciences Acquisition Corp Com Cl A | 0.1 | $5.4M | 500k | 10.82 | |
| Profound Medical Corp Com New (PROF) | 0.1 | $4.3M | 244k | 17.64 | |
| Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $3.8M | 600k | 6.34 | |
| Immatics Nv SHS (IMTX) | 0.1 | $3.7M | 350k | 10.61 | |
| Panacea Acquisition Corp Unit 99/99/9999 | 0.1 | $3.6M | 300k | 12.00 | |
| Chardan Healthcare Acquisition 2 Corp Unit 99/99/9999 | 0.1 | $3.6M | 350k | 10.25 | |
| Progenity | 0.1 | $2.5M | 275k | 9.02 | |
| Twist Bioscience Corp (TWST) | 0.0 | $1.4M | 19k | 75.95 | |
| Burning Rock Biotech Sponsored Ads | 0.0 | $752k | 30k | 25.07 | |
| BiomX Equities Warrant Exp 13 Dec 2023 *w Exp 10/16/202 (PHGEW) | 0.0 | $426k | 600k | 0.71 |
